Analyst Ratings for Maze Therapeutics (MAZE)
MAZE Rating Summary
MAZE Price Target Summary
- Highest: $110.00 (H.C. Wainwright)
- Lowest: $46.00 (Guggenheim)
- Average: $62.73
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$62.73 (+127.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2026 | CIBC | Eric Joseph | New Coverage | Outperformer (N/A) |
50.00 (N/A) |
28.38 (27.53) |
-3% | Details |
| 8/22/2026 | TD Cowen | Phil | New Coverage | Buy (N/A) |
N/A (N/A) |
28.93 (27.53) |
-4.84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
